Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
M.R.M. Merhavit Holding and Management appears to be an Israeli holding and management company rather than a drug developer, biotech, or healthcare operating company. Publicly available records link it to financing, advisory, and transaction activity, including lending arrangements and strategic transactions with Nasdaq-listed SciSparc and Viewbix. The company has also been associated with rights related to an Amazon-based hemp-derived supplements and cosmetics brand, but there is no clear evidence that M.R.M. itself is a life science R&D company with an internal therapeutic pipeline. Based on currently accessible information, it is best characterized as a private investment/holding vehicle with management and financial activities, not a clinical-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on M.R.M. Merchavit Holdings and Management.